This is a community-generated profile. If you would like to claim it, please .
Immunomic Therapeutics Funding
$6.2M
44 rounds
Immunomic Therapeutics is active in the following markets / industries: biotechnology. The company has secured funding across 4 rounds, totaling in an amount of $6.2M. Their most recent funding was raised on April 24, 2014.
Funding Rounds
U
$1000000U
$3000000U
$1600000U
$600000UnknownMar 2010
Investors of Immunomic Therapeutics
Founder, CEO at @Hero. Angel investor.
Founded MedPro Investors, Principal at TriState Ventures
Daniel Geselowitz
Co-Founder, MedPro Investors LLC; Founder, TriState Ventures LLC; Exec Dir, National Constitution Center; Partner, Eaton & Van Winkle LLP; GC, Patlex Corp.;
Exits and consolidation transactions totaling more than $7B, over $600M in financings. From start-up to Fortune 50. Hundreds of millions returned to investors.
Economist/investor. Member: Keiretsu Forum & Keiretsu Coinvestment Fund; E-Fund.
Brian Gaister
Keirestu Forum Member, Active Angel
Life Sciences Greenhouse of Pennsylvania
Rounds
U
World’s Largest Angel Investor Network